The Evolution of Antibody-Drug Conjugates in Oncology - Have We Found Our Magic Bullet?
Yale Cancer Center via YouTube
AI, Data Science & Cloud Certificates from Google, IBM & Meta
Free courses from frontend to fullstack and AI
Overview
AI, Data Science & Cloud Certificates from Google, IBM & Meta — 40% Off
One plan covers every Professional Certificate on Coursera. 40% off Coursera Plus Annual.
Unlock All Certificates
Join Dr. Ian Krop in this Yale Cancer Center Grand Rounds lecture exploring the fascinating evolution of Antibody-Drug Conjugates (ADCs) in cancer treatment and their potential as a "magic bullet" in oncology. Delve into the latest developments, mechanisms, and clinical applications of ADCs, examining how these targeted therapies have transformed cancer treatment approaches. Learn about the current state of ADC technology, its successes and challenges, and gain insights into future directions in this critical area of cancer therapeutics.
Syllabus
The Evolution of Antibody-Drug Conjugates in Oncology: Have we found our “Magic Bullet”? | Dr. Krop
Taught by
Yale Cancer Center